SmithRx Stock

www.smithrx.comHealthcare / Digital HealthFounded: 2016

With a focus on finding a better way to manage employee pharmacy benefits, SmithRx is a pharmacy benefit management (PBM) company that aims to use technology to connect employers and health plan members to specialized programs for pharmaceutical coverage. It provides a platform for small businesses so they can gain transparency and alternative methods to deliver pharmacy benefits. As a result, SmithRX strives to enable employees to access medications that are affordable and easy to acquire while also trying to reduce overhead costs for employers. SmithRx was was founded by Jake Frenz in 2016 and is headquartered in San Francisco, CA.

Register To Buy and Sell Shares

For more details on financing and valuation for SmithRx, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access SmithRx’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like SmithRx.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Jacob Frenz
Founder & Chief Executive Officer

Board Members

Bryan Roberts Ph.D

Frequently Asked Questions About SmithRx’s Stock

Can you buy SmithRx’s stock?
SmithRx is not publicly traded on NYSE or NASDAQ in the U.S. To buy SmithRx’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell SmithRx’s stock?
Yes, you can sell stock of a private company like SmithRx. Forge can help you sell your SmithRx stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is SmithRx’s stock price?
SmithRx is a privately held company and therefore does not have a public stock price. However, you may access SmithRx’s private market stock price with Forge Data.
What is SmithRx’s stock ticker symbol?
SmithRx does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

SmithRx Continues to Fix Broken Pharmacy Benefits Management System, Closes $60M in Series C Funding Led by Venrock
SmithRx, a next-generation pharmacy benefits management (PBM) company, closed a $60M Series C financing round — building on the company’s $20M Series B round raised in 2022. Led by top Silicon Valley healthcare venture capital firm Venrock, the latest funding positions SmithRx to continue reducing costs of pharmacy benefits for small and midsize self-insured businesses.
Updated on: Jun 14, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.